Savers Value Village insider sells 12,402 shares after option exercise

Rhea-AI Filing Summary

Savers Value Village director William T. Allen reported option exercises and a sale of common stock on 08/15/2025. He exercised 12,402 options with a $1.41 exercise price and immediately sold 12,402 shares at $11.15 each under a 10b5-1 plan adopted May 15, 2025, leaving him with 16,655 shares directly owned. After the exercise, he beneficially owns 43,820 shares in total, including 12,402 shares underlying vested options that expire 06/28/2029. The filing was signed by an attorney-in-fact on 08/19/2025.

Positive

• Transactions conducted under a 10b5-1 plan, indicating pre-planned trading rules were followed
• Options exercised had a low exercise price ($1.41), producing intrinsic value when sold at $11.15
• Reporting person retains meaningful beneficial ownership (43,820 shares including options)

Negative

• Insider sold 12,402 shares, which reduces the director's direct share count from 29,057 to 16,655
• Substantial portion of option awards are performance-based and remain subject to future vesting conditions

Insights

Corporate Governance Expert

TL;DR: Insider exercised vested options and sold exercised shares under a pre-established 10b5-1 plan; routine director liquidity event.

The report shows a director-level insider exercised fully vested options and executed an immediate sale for liquidity via a 10b5-1 plan adopted May 15, 2025. The options exercised had a low $1.41 strike relative to the sale price of $11.15, realizing intrinsic value. Remaining beneficial ownership of 43,820 shares includes both exercised shares and unexercised options that expire in 2029. This is a standard, non-accelerated transaction consistent with pre-planned trading and option vesting schedules disclosed in the filing.

Securities Analyst

TL;DR: The insider sale is structured and disclosed; not necessarily a signal of company performance.

The filing documents that 12,402 options vested and were exercised; the sale of those shares was executed under a Rule 10b5-1 plan. The sale price of $11.15 compared with the $1.41 exercise price indicates a material gain to the reporting person but the motion appears procedural rather than reactive. The director retains significant holdings totaling 16,655 directly owned shares post-sale and 43,820 shares beneficially owned when including option interests, which maintains alignment with shareholders.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ALLEN WILLIAM T

(Last) (First) (Middle)

C/O SAVERS VALUE VILLAGE, INC.

11400 SE 6TH, SUITE 125

(Street)

BELLEVUE WA 98004

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Savers Value Village, Inc. [ SVV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/15/2025		M		12,402	A	$1.41	29,057	D
Common Stock	08/15/2025		S(1)		12,402	D	$11.15	16,655	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (Right to Purchase)(2)	$1.41	08/15/2025		M			12,402	(3)	06/28/2029	Common Stock	12,402	$1.41	43,820(4)	D

Explanation of Responses:

1. The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on May 15, 2025.

2. Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions.

3. The June 28, 2019 stock option grant vested in substantially equal annual installments over five years starting May 20, 2020, and was fully vested on May 20, 2024.

4. Approximately 15% represents time-based options with a vesting schedule in substantially equal annual installments over five years starting May 2, 2020, and approximately 85% represents performance-based options, of which 25% vested upon the initial public offering and the remainder will be eligible for vesting upon satisfaction of certain performance criteria including stock price performance.

Remarks:

	/s/ Richard Medway, attorney in fact	08/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did William T. Allen report on Form 4 for SVV?

He exercised 12,402 options at $1.41 and sold 12,402 shares at $11.15 on 08/15/2025 under a 10b5-1 plan.

How many SVV shares does the reporting person beneficially own after the transactions?

He beneficially owns 43,820 shares in total and 16,655 shares directly after the reported transactions.

Were the sales pre-planned or discretionary?

The sale was executed pursuant to a 10b5-1 plan adopted May 15, 2025, indicating it was pre-planned.

What is the expiration date for the underlying options?

Some options underlying the reported interest expire on 06/28/2029.

Did the filing disclose when the options vested?

Yes; the specific grant vested over five years and was fully vested on May 20, 2024, per the filing.